High initial drug resistance in pulmonary tuberculosis in Ghana

Fox, 1979, The chemotherapy of pulmonary tuberculosis: a review, Chest, 76, 771, 10.1378/chest.76.6_Supplement.785 Toman, 1979 Grzybowski, 1985, The impact of treatment programmes on the epidemiology of tuberculosis, Tubercle, 66, 69, 10.1016/0041-3879(85)90057-1 Kleeberg, 1984 Gibson, 1986, Drug-resistant tuberculosis in Sierra Leone, Tubercle, 67, 119, 10.1016/0041-3879(86)90005-X Sodhi, 1966, Drug resistance of tubercle bacilli isolated in Accra, Ghana Med J, 44 Mitchison, 1986, Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis, Am Rev Respir Dis, 133, 423 Collins, 1982, Subdivision of Mycobacterium tuberculosis into five variants for epidemiological purposes: methods and nomenclature, J Hyg, 89, 235, 10.1017/S0022172400070765 Castets, 1969, La variété africaine du bacille tuberculeux humain, Méd Afrique Noire, 16, 321 Grange, 1988, The species of Mycobacteria, 31 Lefford, 1969, The sensitivity to thiacetazone and para-aminosalicylic acid and the virulence in the guinea pig of East African strains of Mycobacterium tuberculosis, Tubercle, 50, 1, 10.1016/0041-3879(69)90002-6 Zykov, 1972, Characteristics of Mycobacterium tuberculosis in Africa-Vulnerable and invulnerable types of drug resistance, Am Rev Respir Dis, 105, 715 Mitchison, 1969, Natural sensitivity of M. tuberculosis to thiacetazone, Tubercle, 38 Shimao, 1987, Drug resistance in tuberculosis control, Tubercle, 68, 5, 10.1016/S0041-3879(87)80014-4 1983, Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. Fifth Collaborative Study, First Report, Tubercle, 64, 153, 10.1016/0041-3879(83)90011-9 Girling, 1982, Adverse effects of antituberculosis drugs, Drugs, 23, 56, 10.2165/00003495-198223010-00003 Grange, 1988, Therapy of Mycobacterial disease, 153